8XU-17954-76368
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 281 / NC
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Pfizer-BioNTech
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
-
2021-01-23
Dose 2 — Pfizer-BioNTech
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-03-09
-
2021-07-24
Survey response — 6 months, dose 2MedDRA: Headache — Feeling: GoodFree text: Periodic headaches that fade in and out after 2 minutes. The occurrence of headaches seems to be at random and throughout the day everyday since being fully vaccinated.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-23 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Periodic headaches that fade in and out after 2 minutes. The occurrence of headaches seems to be at random and throughout the day everyday since being fully vaccinated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release